Equities

Treace Medical Concepts Inc

TMCI:NSQ

Treace Medical Concepts Inc

Actions
  • Price (USD)5.48
  • Today's Change0.270 / 5.18%
  • Shares traded1.30m
  • 1 Year change-62.23%
  • Beta0.2268
Data delayed at least 15 minutes, as of Sep 18 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.

  • Revenue in USD (TTM)198.53m
  • Net income in USD-63.68m
  • Incorporated2014
  • Employees516.00
  • Location
    Treace Medical Concepts Inc100 Palmetto Park PlacePONTE VEDRA 32081United StatesUSA
  • Phone+1 (904) 373-5940
  • Fax+1 (904) 834-7169
  • Websitehttps://www.treace.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Alpha Teknova Inc34.94m-34.27m254.26m210.00--2.47--7.28-0.9295-0.92950.91671.930.28192.366.84166,381.00-27.65---32.36--22.38---98.08--3.28-29.500.144---11.43--22.52------
Inogen Inc326.65m-92.44m257.11m834.00--1.37--0.7871-3.97-3.9713.977.910.95626.857.49391,670.30-27.06-8.23-33.51-9.5342.5644.54-28.30-10.312.37--0.00---16.32-2.49-22.30--26.34--
Zynex Inc193.61m6.04m259.97m1.10k47.238.0624.571.340.17340.17345.731.021.412.566.85176,012.704.4014.584.9917.5280.3679.623.1210.443.225.740.642--16.5442.01-42.910.37412.19--
Delcath Systems Inc11.88m-56.33m262.64m76.00--62.50--22.11-2.55-2.550.5050.15010.43220.61986.17156,289.50-204.97-116.57-356.98-243.2177.0571.02-474.22-1,235.372.04-54.370.5172---24.05-9.53-30.60---5.26--
Atlantic International Corp205.26m-62.29m306.99m7.00--12.07--1.50-8.72-8.7214.590.52222.91--7.0329,322,780.00-88.44-71.97-174.30-106.0910.7061.01-30.35-1,471.82---1.330.7735---100.00---37.43------
AngioDynamics, Inc.303.91m-184.35m307.71m748.00--1.50--1.01-4.57-4.577.565.080.71482.576.30406,302.10-43.36-16.38-54.60-18.7050.9052.95-60.66-30.491.46--0.00---10.282.35-251.53--13.09--
Pulmonx Corp76.58m-57.86m320.27m279.00--3.17--4.18-1.50-1.501.992.580.41881.217.65274,491.00-31.64-26.27-35.08-28.9774.1971.95-75.56-93.767.92--0.2688--27.9827.98-3.26--20.62--
Treace Medical Concepts Inc198.53m-63.68m324.01m516.00--2.89--1.63-1.03-1.033.211.800.83471.147.52384,753.90-26.77---31.74--80.67---32.08--2.93--0.3216--31.92---15.68------
OraSure Technologies, Inc.273.54m27.03m327.35m638.0012.160.76878.211.200.36110.36113.685.710.59472.726.02428,738.306.000.72386.530.821244.6246.9410.091.1310.84--0.00180.004.6417.41413.1782.2010.18--
Clearpoint Neuro Inc28.07m-17.98m328.94m107.00--10.23--11.72-0.7062-0.70621.101.160.56021.318.95262,327.10-35.89-34.75-46.51-39.6759.8564.75-64.06-76.912.31--0.237--16.5626.64-34.40--75.30--
Tactile Systems Technology Inc281.54m32.59m337.93m992.0010.331.688.621.201.371.3711.818.371.027.106.36283,814.5011.800.901513.871.0950.6349.1011.580.83093.89--0.12110.0011.2013.81259.6033.91-23.62--
Sight Sciences Inc79.40m-52.32m343.60m214.00--3.37--4.33-1.06-1.061.612.030.4741.534.18371,004.70-31.24-38.78-34.01-42.2085.8080.74-65.90-105.1410.50-26.500.2494--13.6360.8435.59--6.77--
Cerus Corp194.51m-24.06m365.04m288.00--7.37--1.88-0.1319-0.13191.070.26731.011.988.40675,371.50-12.56-25.99-19.03-40.6260.7961.90-12.41-35.811.83-1.510.6244---0.806119.6912.37--32.07--
Nano-X Imaging Ltd10.13m-57.47m372.63m164.00--2.13--36.79-0.9974-0.99740.17552.990.0482--6.8961,756.10-27.33-30.98-29.96-35.10-81.80---567.41-1,527.245.09--0.0181--15.47--46.33--114.35--
Anika Therapeutics Inc166.88m-74.18m372.88m357.00--1.78--2.23-5.06-5.0611.3514.170.56421.344.73467,451.00-25.08-5.41-27.37-5.8762.1660.70-44.45-12.603.96--0.00--6.679.56-456.34--3.11--
Jin Medical International Ltd20.13m2.91m407.02m245.00139.4915.51133.5520.220.01860.01860.12920.16760.55762.384.2282,143.597.8012.8111.2720.9234.7333.5813.9914.602.27--0.27020.003.29-1.076.34-4.80-9.50--
Data as of Sep 18 2024. Currency figures normalised to Treace Medical Concepts Inc's reporting currency: US Dollar USD

Institutional shareholders

43.69%Per cent of shares held by top holders
HolderShares% Held
Armistice Capital LLCas of 30 Jun 20245.36m8.62%
William Blair Investment Management LLCas of 30 Jun 20243.70m5.95%
BlackRock Fund Advisorsas of 30 Jun 20243.52m5.65%
The Vanguard Group, Inc.as of 30 Jun 20243.49m5.62%
Morgan Stanley & Co. LLCas of 30 Jun 20242.74m4.40%
Soleus Capital Management LP (Investment Management)as of 30 Jun 20242.37m3.80%
DWS Investments (UK) Ltd.as of 30 Jun 20242.05m3.29%
CIBC Private Wealth Advisors, Inc.as of 30 Jun 20241.93m3.10%
Geode Capital Management LLCas of 30 Jun 20241.06m1.71%
SSgA Funds Management, Inc.as of 30 Jun 2024957.55k1.54%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.